Matritech Inc/DE/ - Current report filing (8-K)
25 10월 2007 - 5:25AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT PURSUANT
TO
SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date
of
Report (Date of earliest event reported)
October
24, 2007
Matritech,
Inc.
(Exact
name of registrant as specified in its charter)
Delaware
|
001-12128
|
04-2985132
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
330
Nevada Street, Newton, Massachusetts
|
02460
|
(Address
of principal executive offices)
|
(Zip
Code)
|
(617)
928-0820
(
Registrant’s
telephone number, including area code
)
Not
applicable
(Former
name or former address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (
see
General
Instruction A.2. below):
x
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
8.01
Other
Events.
On
October 24, 2007, Matritech, Inc.
issued a press release announcing that, in connection with the proposed
acquisition by Inverness Medical Innovations, Inc. of substantially all of
Matritech’s assets, on October 23, 2007, Inverness filed an initial Registration
Statement on Form S-4 that includes a preliminary proxy statement for a special
meeting of the Matritech stockholders. A copy of this press release
is attached hereto as Exhibit 99.1.
Item
9.01
Financial Statements
and Exhibits.
|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
99.1
|
|
Press
Release issued by Registrant on October 24, 2007 announcing
the filing by
Inverness Medical Innovations, Inc. of an initial Registration
Statement
on Form S-4 that includes a preliminary proxy statement for
a special
meeting of Matritech’s stockholders.
|
|
|
|
|
|
|
|
|
SIGNATURES
Pursuant
to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report
to
be signed on its behalf by the undersigned hereunto duly
authorized.
|
MATRITECH,
INC.
|
|
|
|
|
|
|
|
|
|
|
|
Date
October 24, 2007
|
By:
|
/s/ Richard
A. Sandberg
|
|
|
|
Name: Richard
A. Sandberg
|
|
|
|
Title:
Chief Financial Officer
|
|
|
|
|
|
EXHIBIT
INDEX
Exhibit
No.
|
|
Description
|
|
|
|
99.1
|
|
Press
Release issued by Registrant on October 24, 2007 announcing
the filing by
Inverness Medical Innovations, Inc. of an initial Registration
Statement
on Form S-4 that includes a preliminary proxy statement
for a special
meeting of Matritech’s stockholders.
|
|
|
|
|
|
|
Matritech (AMEX:MZT)
과거 데이터 주식 차트
부터 8월(8) 2024 으로 9월(9) 2024
Matritech (AMEX:MZT)
과거 데이터 주식 차트
부터 9월(9) 2023 으로 9월(9) 2024
Matritech, (아메리카 증권거래소)의 실시간 뉴스: 최근 기사 0
More Matritech Inc/DE/ News Articles